1. Introduction {#s0005}
===============

An estimated 12 million people are currently infected by *Leishmania* parasites, including the visceral (VL), cutaneous (CL) and mucocutaneous forms of the disease ([www.who.int/leishmaniasis/](http://www.who.int/leishmaniasis/)). The species of the *Leishmania donovani* complex cause the most severe type of leishmaniasis (VL) in tropical and sub-tropical regions -- though asymptomatic infections are common ([@b0240]). Unlike the other *Leishmania* parasites, those causing VL disseminate to internal organs and are responsible for 50,000 deaths and the loss of over 2.3 million disability-adjusted life years annually ([@b0360]). The number of people in India, Nepal and Bangladesh at risk of infection is 190 million and the annual volume of cases in India is over 100,000 -- mostly occur in the north-western Indian state of Bihar, adjacent to the Terai region of Nepal, where VL is also endemic ([@b0290]). This shows the scale of the disease burden and the challenge in combating VL as detailed in the first regional programme of VL elimination in the Indian subcontinent by 2015 ([@b0335]).

As a result, improved molecular tools are vital for monitoring the epidemiology and diversity of strains in the *L. donovani* species complex. A wide variety of approaches has been applied, including those using multilocus enzyme electrophoresis ([@b0245]), sequencing of ribosomal loci ([@b0155]), microsatellite typing (for example, [@b0220]), gene sequences (for example, [@b0190]), random amplification of polymorphic DNA ([@b0040]), amplified fragment length polymorphisms (for example, [@b0150]) and kinetoplastid minicircle DNA (kDNA) restriction fragment length polymorphisms (RFLP; for example, [@b0170]). Among this multitude of approaches used to assess diversity, kDNA RFLP and multi-locus microsatellite typing (MLMT) have proven to be highly discriminatory for typing *L. donovani* species complex parasites ([@b0040]). Although kDNA diversity can be informative, the variability in both experimental replication ([@b0035]) and total DNA yield ([@b0085]) limit the effectiveness of this approach. Nonetheless, the hypothesis of multiple origins for drug resistance in these parasites stems from kDNA variation in Nepalese *L. donovani* ([@b0170]), and was supported by genome-wide variability ([@b0085]).

MLMT has been used extensively for typing strains of the *L. donovani* complex. An initial study investigating variation in 15 microsatellite markers for 91 strains of the *L. donovani* complex from different VL foci in the Mediterranean Basin, East Africa and the Bihar state of India highlighted significant differentiation between the continental groups ([@b0160]). However, in contrast to strains from East Africa and the Mediterranean that appeared to be highly variable, Bihari strains had little microsatellite profile diversity. Improved sampling of more and newly isolated strains from Bihar, Nepal and Bangladesh with MLMT suggested that *L. donovani* strains in the Indian subcontinent showed genetic homogeneity regardless of geographical origin, clinical manifestation, and whether they presented *in vitro* or *in vivo* susceptibility to antimonial drugs ([@b0005]). This result was reflected in the poor resolution of MLMT as well as also PCR-RFLP targeting kDNA and genomic coding sequences to clearly determine the genetic relationships of Nepalese strains ([@b0035]). In contrast, wider MLMT analysis of *L. infantum* strains from Europe and South America (*N* = 406), and of East African *L. donovani* (*N* = 123) further supported their considerable diversity ([@b0120; @b0145]).

With ongoing improvements in sequencing technology, genome-wide SNP typing represents a powerful alternative approach for differentiating parasite strains ([@b0185]). In this study, we sought to elucidate the variation in the *L. donovani* complex firstly within a population and secondly between species using SNP and microsatellite genotyping, while also comparing the power of each marker type. While both methods were effective at discriminating isolates over long geographic distances, informing on the population history of *Leishmania* strains, microsatellites lacked sufficient power to resolve diversity in closely related strains of Nepalese and Indian *L. donovani*. In contrast, genome-wide SNP variation provided new evolutionary insights into the ongoing diversification of this phenotypically variable set of strains, potential links between the genotypes of the strains with *in vitro* sodium stibogluconate (SSG) resistance, as well as identifying protein sequence mutations that may underlie the phenotypic differences.

2. Material and methods {#s0010}
=======================

2.1. Sample collection {#s0015}
----------------------

To compare the discriminatory power of microsatellite and SNP typing for unravelling diversity within a set of genetically homogeneous *L. donovani*, 25 clinical isolates taken from a small focus with endemic VL in the Indian subcontinent were examined by assaying their microsatellite and SNP genotypes ([Supplementary Fig. 1](#s0080){ref-type="sec"}). These parasites were isolated n the Terai area of Nepal (23) and the nearby Indian state of Bihar (two). Each isolate was independently taken from unique VL patients (with the exception of two strains from BPK173; [@b0240]). The genomes of 17 of these have been scrutinised ([@b0085]) and so eight of the Nepalese strains represent entirely new samples assessed using both SNPs and microsatellites ([Table 1](#t0015){ref-type="table"}). DNA was isolated and phenotype responses were assessed for *in vitro* susceptibility to SSG relative to the Nepalese reference genome (BPK282/0cl04, see [Supplementary data](#s0080){ref-type="sec"}) for lines not already assessed ([@b0235; @b0085]). In total, nine clinical samples were classed as resistant and 15 as sensitive (the phenotype of BPK077/0cl5 was not determined).

Genetic variation between strains of the *L. donovani* complex from different continents was studied using both marker types to frame diversity observed with the Terai-Bihar region. Five additional *L. donovani* strains originally taken in Sri Lanka (L60b), Kenya (LRC-L53, NLB218), Sudan (597LN), Ethiopia (GEBRE1), as well as three *L. infantum* from China (D2) and France (LPN114, LRC-L47) were assessed. All of these caused VL or PKDL except L60b, whose pathology was cutaneous (CL): this strain was closely related to other Sri Lankan ones causing CL ([@b0005]). Genome, enzyme and microsatellite markers have been previously used to classify these eight samples ([@b0155; @b0160; @b0190; @b0365; @b0350; @b0165]), leading to their usage here as informative representatives of genetic variation in the wider *L. donovani* complex. Ethiopian GEBRE1 and the Kenyan strains LRC-L53 and NLB218 are representatives of East African diversity, though NLB218 may be more divergent within this group ([@b0005]). Among the *L. infantum* samples, French strain LPN114 represents Mediterranean strains belonging to zymodeme MON-1. Strains LRC-L47 (France) and D2 (China) are part of the non-MON-1 group, though D2 has a more divergent genetic profile ([@b0155; @b0160]).

2.2. Microsatellite profiling {#s0020}
-----------------------------

In light of the extensive research already performed on microsatellite variability in *L. donovani*, a combination of new and existing microsatellite data yielded a total 193 strains of the *L. donovani* complex that were investigated here. Analysis of variation in tandem repeat numbers at 15 unlinked microsatellites ([Supplementary Table 1](#s0080){ref-type="sec"}) was completed for 41 newly typed strains from Bangladesh, the Bihar state of India and Terai region of Nepal ([Supplementary Table 2](#s0080){ref-type="sec"}). Their microsatellite profiles were compared to those of 152 strains previously studied of which 25 came from African and European foci endemic for VL ([@b0220; @b0160; @b0005; @b0035]). Of the 193 strains, 168 strains were from the Indian subcontinent, 17 *L. donovani* strains from Sudan (7), Kenya (7), and Ethiopia (3), and eight genetically diverse strains of *L. infantum* were from France (3), China (3), Spain (1) and Tunisia (1). The strains of *L. infantum* represented the MON-1 and different non-MON-1 zymodemes ([@b0220; @b0160]).

PCR amplification and determination of the DNA fragment sizes was performed as described elsewhere ([@b0220; @b0160]). Ten of the 15 microsatellite markers were invariant in the previously published strains from the Indian subcontinent ([@b0220; @b0160; @b0005]) and, consequently, five markers (Lm4TA, TubCA, B_Li41-56, F_Li23-41 and CS20) were amplified in the 41 newly typed strains ([Supplementary Table 1](#s0080){ref-type="sec"}).

2.3. SNP genotyping {#s0025}
-------------------

SNP variation was examined in the 33 strains (23 Nepalese, two Indian and eight globally diverse *L. donovani* complex strains) out of the 193 strains discussed above. Five Nepalese clones taken from the same patients as three of the 23 Nepalese strains were also analysed to investigate the isolates' heterogeneity (BPK085/0cl8, BPK085/0cl3, BPK275/0cl3, BPK2880cl7, BPK288/0cl9; see [Supplementary Results](#s0080){ref-type="sec"}).

The SNP loci used here were selected from 3549 SNPs discovered in the genomes of 17 strains ([@b0085]). Among this initial dataset, we focused on intermediate-frequency variants to maximise discriminating power. Candidate sites were screened using multiple steps: first, SNPs close to other ones (±200 bp) were excluded, because the amplification process was allele-specific. Second, sites whose adjacent ±100 bp had GC content levels \<30% or \>70% were excluded. Third, genome-wide BLAST (Basic Local Alignment Search Tool, [@b0020]) alignments of the candidate regions were used to eliminate non-unique loci (*E*-value \< 10^−4^). Fourth, sites were examined using alignments of the *L. donovani* and *infantum* genomes with the Artemis Comparison Tool ([@b0060]) to remove those with evidence of structural variation. A final set of 130 SNPs was obtained, each of which was unique in the *L. donovani* genome: 82 were in coding sequences, of which 51 were nonsynonymous (protein-level) and 31 were synonymous.

Genotyping was conducted in duplicate using mass spectrophotometry of allele-specific amplified DNA on the Sequenom platform ([@b0050]): SNP site signal detection had a 98.8% success rate (4881/4940). Genomic positions, local sequence, observed genotypes, gene information and GC content of the SNPs are available as a [Supplementary file](#s0080){ref-type="sec"} (GenotypingSupplData.xls).

2.4. Population genetic analysis of SNP and microsatellite data {#s0030}
---------------------------------------------------------------

In order to develop a comprehensive genetic picture of diversity at the SNP loci, several complementary tools were applied. Analysis of population structure was conducted using a Bayesian population-clustering algorithm to estimate the most likely extent of differentiation between groups of strains independent of a mutation model, and quantified this in an unbiased probabilistic manner to assign strains to discrete populations (Structure v2.3.3; [@b0225]). Strains were clustered based on their relative similarity to obtain their probability of membership to each population and inferred ancestry values. The most likely number of populations (*K*) was determined from the likelihood values for each model and their first and second-order rates of change (L(*K*), L(*K*)′, Δ*K*, respectively, [@b0100]). Admixture modelling assigned strains to clusters and permitted incomplete membership to minimise overfitting ([@b0105]). A burn-in of 10^5^ and run of 2 × 10^6^ steps were used for each simulation conducted in sets of 10 for 1 ⩽ *K* ⩽ 15.

Further elucidation of the SNP-based phylogenetic signals within the cohort was achieved using neighbour-joining trees ([@b0265]) using the maximum composite likelihood method ([@b0295]) in MEGA v5 ([@b0300]), as well as median-joining networks (Network v4.2.0.1, [@b0025]) and principal component analysis. The greater circle arc distance between the samples' point of isolation was used to determine the effect of geography on diversity. *F*~ST~ values ([@b0345]) were determined for each group (Arlequin v2.001, [@b0275]). Predictions of the functional impact of non-synonymous substitutions on overall protein structure were implemented for SNPs discriminating the major strain subsets for substitutions with significant support (SIFT, <http://blocks.fhcrc.org>, [@b0210]; and PolyPhen, <http://genetics.bwh.harvard.edu.pph>, [@b0230]).

In order to compare genetic diversity inferred from both SNPs and microsatellites, parallel analyses were implemented where possible. Consequently, the microsatellite-derived population structure was determined using the same distance-based and Bayesian population-resolution methods. A strain-based genetic distance matrix was calculated based on the proportions of alleles shared between strains (*D*~AS~) based on pairwise distances ([@b0045]) with Populations (v1.2.31, <http://bioinformatics.org>) to resolve the phylogenetic relationships in neighbour-joining trees (MEGA v5).

The Bayesian clustering approach estimated the population structure as outlined above for the SNPs (Structure v2.3.3, [@b0225]). L(*K*), L(*K*)′ and Δ*K* were computed from 50 runs for 1 ⩽ *K* ⩽ 15 using a burn-in of 10^4^ and a run length of 10^5^ iterations. The degree of genetic differentiation among the geographic populations was examined using an infinite alleles model for *K* = 3 (Microsatellite Analyser v4.05, [@b0080]). For each microsatellite, allelic diversity for each population was calculated for the number of individuals, the proportion of polymorphic loci (where the minor allele frequency \>0.01), number of alleles, the mean number of alleles, alleles per polymorphic locus, the expected and observed heterozygosity using permutation methods assuming Hardy--Weinberg equilibrium (Genetic Data Analysis v1.0, <http://hydrodictyon.eeb.uconn.edu>).

To gain an insight into the evolutionary history of the strains studied, we investigated changes in the effective population size (*N*~e~) using Bayesian skyline plots implemented with Beast v1.6.2, Tracer v1.5.0, TreeAnnotator v1.6.2 and Figtree v1.3.1 ([@b0095; @b0090]). Posterior density intervals were calculated for the Bihar-Terai strains, both with and without the outgroup strains or divergent strains from the same region, to compute the relative changes in *N*~e~. Time was scaled using a generation length of one day and *N*~e~ was estimated using a mutation rate of 10^−6^ as outlined previously ([@b0175]).

3. Results and discussion {#s0035}
=========================

By compiling SNP and microsatellite variation in a set of *L. donovani* strains from a small area of Nepal and India, population genetic patterns of variation were examined in the context of a globally diverse range of strains. In total, 33 strains were assessed using both SNPs (130) and microsatellites (15): these came from Nepal (23), India (2), France (2), Kenya (2), China (1), Ethiopia (1), Sri Lanka (1) and Sudan (1). The contrasting power of these two genetic markers to resolve population-level differentiation emphasizes relative advantages of genome-wide data and well-established approaches in evaluating diversity in *Leishmania* parasites.

3.1. Microsatellite population structure in the *L. donovani* complex {#s0040}
---------------------------------------------------------------------

Two genetic distance approaches were applied to microsatellite profiles of 193 strains from globally distributed endemic foci. Bayesian clustering of the samples into groups identified three main phylogenetically distinct population clusters (*K* = 3, [Supplementary Fig. 2](#s0080){ref-type="sec"}) that appeared to reflect the geographical origins of the strains, consistent with earlier work ([@b0160; @b0120]). Both Bayesian statistics and genetic distance analyses confirmed the major genetic groups that have been previously identified ([@b0005]).

The largest cluster (In^1,2^NpBdLk) consisted of 164 of the 168 strains from the Indian subcontinent ([Fig. 1](#f0005){ref-type="fig"}, [Supplementary Table 2](#s0080){ref-type="sec"}). This cluster contained 52 strains from Nepal, 88 from India (mainly from Bihar), 21 from Bangladesh, one from the Northwest of India, and two strains from Sri Lanka. Nineteen microsatellite profiles were identified for the strains belonging to In^1,2^NpBdLk of which eight were newly identified in this study. Although 108 strains had an identical microsatellite profile (1a) and most other strains varied at just one marker, there was some differentiation for three Nepalese strains (BPK026/0cl5, BPK031/0cl12 and BPK406/6) within In^1,2^NpBdLk ([Fig. 1](#f0005){ref-type="fig"}). The two Sri Lankan strains (L60b and L60c), the only ones in this study isolated from CL cases, and the northwest Indian isolate from Chandigarh appeared as most diverse members of In^1,2^NpBdLk. These three strains shared alleles with strains of both In^1,2^NpBdLk and KeSdEtIn^3,4^, so further sampling is required to clarify their intermediate phylogenetic position ([Fig. 2](#f0010){ref-type="fig"}A). Despite moderate variation in these six strains, the general pattern of high genetic homogeneity for In^1,2^NpBdLk was also illustrated by its low observed heterozygosity (0.005) compared to that of KeSdEtIn^3,4^ (0.159; [Supplementary Table 3](#s0080){ref-type="sec"}).

The second main population (KeSdEtIn^3,4^) contained four Indian strains (L13, LRC-L51a, LRC-L51p and SC23) genetically distinct from the Nepalese and Bihari samples as well as the strains of *L. donovani* from Sudan, Ethiopia and Kenya included in this study ([Fig. 1](#f0005){ref-type="fig"}). These Indian strains were isolated more than 40 years ago and therefore might represent a relic of greater diversity of *L. donovani* existing prior to the 1960s DDT anti-malaria spraying campaigns in the Indian subcontinent ([@b0360]). Strains from East Africa were previously shown to belong to two major genetic groups: those from Sudan and North Ethiopia, and also samples from Kenya and South Ethiopia were assigned to different populations, concurring with the existence of different sand fly vectors in the different foci ([@b0160; @b0120]). The same subdivision of population KeSdEtIn^3,4^ was evident here from the population clustering and distance analyses ([Fig. 1](#f0005){ref-type="fig"}). One strain isolated from an Indian patient (L13) always grouped with strains from Sudan and Ethiopia whereas the remaining Indian strains (SC23, LRC-L51a, LRC-L51p) clustered with the Kenyan strains essentially as described before ([@b0005]). When the three main geographically defined populations were re-analysed with Structure separately, five genetically distinct sub-populations could be identified that were confirmed by factorial correspondence analysis ([Supplementary Fig. 3](#s0080){ref-type="sec"}): this was consistent with previous findings ([@b0005]).

Several patterns emerge from the microsatellite analysis of these strains. The loss of genetic variation within the main Indian cluster might well be a consequence of a population bottleneck related to the DDT spraying efforts. As a result, the population history of the strains studied here from the Indian sub-continent may be composed of a series of periodic expansions from an inferred low number of surviving lineages. This scenario would have been accompanied by a rapid recovery of population size reaching endemic proportions in the main foci in recent decades. Bottlenecks tend to reduce variation at neutral genomic regions like microsatellites, supporting this scenario ([@b0205]). On the other hand, it cannot be excluded that migration of workers between the East Africa and the Indian subcontinent could also have lead to the occurrence of similar profiles in these geographically isolated foci represented by the KeSdEtIn^3,4^ group. However, the four strains from India clustering with the African clades (SC23, LRC-L51a, LRC-L51p, L13; [Fig. 1](#f0005){ref-type="fig"}) were all isolated prior or close to strains isolated during the DDT vector elimination program, which favours the bottleneck hypothesis. The number and type of microsatellite alleles appear to trace the phylogenetic history of these Indian samples back to common ancestors within the African cluster, and to some degree for the Sri Lankan and Chandigarh strains.

This lack of variation in samples from Nepal and Bihar was pronounced when compared to the high differentiation observed among other strains sampled in Europe, Asia and Africa. Consequently, although variability among these 15 microsatellites was effective for discriminating geographically distant isolates of the *L. donovani* complex, little genetic resolution of population-level variability for the strains from the Indian subcontinent was found, in spite of the high microsatellite diversity described for strains of *L. donovani* from East Africa and *L. infantum* from the Mediterranean area and South America ([@b0160; @b0165; @b0120; @b0145; @b0175]).

3.2. SNP population structure in the *L. donovani* complex {#s0045}
----------------------------------------------------------

Strains were assigned to four distinct populations in the set of 33 strains examined at 130 SNPs ([Supplementary Table 4](#s0080){ref-type="sec"}). The first of these four to differentiate from the rest was composed of strains from Sudan (1), Ethiopia (1), Kenya (2), Sri Lanka (1), France (2), China (1), and two strains from Nepal (BPK026/0cl5 and BPK031/0cl12). For *K* \> 1 population clusters, BPK026/0cl5 and BPK031/0cl12 consistently grouped with these diverse *Leishmania* strains, indicating their higher genetic identity with these rather than the geographically close Nepalese and Bihari strains. Notably, this pair was originally taken from an upland region where VL was not endemic at the time of isolation ([@b0035]).

The second, third and fourth populations (referred to as In/Np 1, 2 and 3) were composed entirely of Nepalese and Indian strains ([Fig. 2](#f0010){ref-type="fig"}B). These patterns mirrored the microsatellite data: the Nepalese and Indian strains showed lower diversity in comparison to the other strains. In spite of this, the 130 SNPs used here were sufficient to uniquely resolve 29 of the 33 strains ([Supplementary Fig. 4](#s0080){ref-type="sec"}) and presented the novel observation of a divergent lineage (BPK026/0cl5 and BPK031/0cl12). Although the most likely number of groups here suggested a total of five populations (*K* = 5), no strains were assigned to the additional putative group, suggesting that this was not a valid population for this set ([@b0100; @b0135]). However, this phantom group was also evident for at *K* = 4, prior to the separate clustering of the In/Np populations 1 and 2, suggesting a wider and deeper clinical sample collection may discover new diversity even in this small geographic area.

The phylogenetic clustering of SSG-resistant and -susceptible strains supported the complex origins of resistance ([Supplementary Fig. 5](#s0080){ref-type="sec"}). Furthermore, the absence of any SSG-sensitive strains in In/Np 3 suggested this group could share a recent single origin. There was no evidence of a notable contribution of geography to intra-population SNP diversity as expected, probably a consequence of local host migration and the small region size ([@b0085]). In sharp contrast to the lack of local geographic structure within Nepal and Bihar, the level of differentiation of the three In/Np populations from both the *L. infantum* (*F*~ST~ = 0.64) and combined African and Sri Lankan *L. donovani* (0.56) strains matched that of previous work on European, Asian and African strains ([@b0365; @b0160; @b0120]).

Reconstructing the population history using Bayesian skyline plots provided evidence that the strains from Bihar and Terai have undergone a recent bottleneck followed by a slight increase ([Supplementary Fig. 6](#s0080){ref-type="sec"}). This trend was robust to the inclusion of divergent strains, though the magnitude of change in effective population size decreased. Using the calibration of the *L. infantum*--*L. chagasi* split between Europe and South America ([@b0175]) and the time of isolation of the Nepalese sample (2002--03), the lowest effective population size dates the population recovery for this subset to recently after the Indian parasite elimination programs (1974--84 with 95% limits).

3.3. Congruence in population structure between SNPs and microsatellites {#s0050}
------------------------------------------------------------------------

By performing parallel investigations of population structure using the 33 strains that were typed with both SNP and microsatellite markers, the relative capacity of each approach to distinguish both distantly and closely related strains was assessed. Large genetic distances for both marker types were evident in the phylogenetic trees and population cluster modelling for isolates sampled in distant geographic locations. Both SNP and microsatellite markers distinctly partitioned the eight globally diverse isolates from Sudan, Ethiopia, Kenya, France, China and Sri Lanka from one another, and clearly separated these from the Indian subcontinent *L. donovani* strains ([Fig. 2](#f0010){ref-type="fig"}). Notably, the Sri Lankan strains had an intermediate position between the microsatellite-defined populations In^1,2^NpBdLk and KeSdEtIn^3,4^ when the complete set of 193 strains was analysed, but were assigned to the African group (KeSdEtLk) in the analysis on the 33 strains ([Fig. 3](#f0015){ref-type="fig"}).

Further resolution of the intraspecific population structure for strains from Nepal and Bihar was only clearly demonstrated by SNP typing, which allowed the discovery of a novel lineage from the Terai region of Nepal in a relatively homogeneous population according to microsatellite results ([Fig. 2](#f0010){ref-type="fig"}). These two strains (BPK026/0cl5 and BPK031/0cl12) were taken from patients with VL and yet were more closely related to the Sri Lankan strain from a case of CL than the isolates of *L. infantum* and African *L. donovani* that caused VL or PKDL. The genetic uniqueness of this lineage was first identified in kDNA ([@b0035]), and was also supported by MLMT here that phylogenetically differentiated this pair along with BPK406/6 from the rest of the Nepal-Bihar cluster ([Fig. 1](#f0005){ref-type="fig"}).

The SNP-based genetic distances between the *L. infantum* and African *L. donovani* used here as outgroup strains were generally greater than those within the cohort from Nepal and India. Although our set of SNPs was originally designed for elucidating diversity among *L. donovani* from the Indian subcontinent, it also resolved the phylogenetic relationships of other strains of the *L. donovani* complex. However, the relative genetic distances between the outgroup strains and Nepalese-Indian population as measured by microsatellites and SNPs differed. Thus, microsatellites remain an effective means of identifying major genetic groups in a quantifiable manner, though clearly our panel of SNPs was superior in resolving strains within geographical populations.

In contrast to the limited resolving capacity of microsatellites within the Indian subcontinent population, this study presented clear evidence of the power of SNPs to discriminate between strains in a phenotypically diverse population of *L. donovani*. Moreover, certain strains presented high numbers of unique SNPs (like BPK067/0cl2 and BPK294/0cl1) suggesting the presence of further distinct clusters of diversity and highlighting a need for deeper sampling not apparent from microsatellite analysis alone. Furthermore, strains from Calcutta in India (LRC-L51a, LRC-L51p, SC23) clustered with the Kenyan ones and were genetically distinct from other Indian subcontinent strains, underscoring the potential for divergent lineages from the same endemic focus to be infectious in addition to illustrating the need to probe further the ancestry of Indian and African *Leishmania*.

3.4. Functional variation in the *L. donovani* complex {#s0055}
------------------------------------------------------

An advantage of using SNPs to characterise evolutionary and population variation is the inclusion of protein-level sequence substitutions that can elicit functionally relevant changes ([Supplementary Fig. 5](#s0080){ref-type="sec"}). Here, we examined mutations differing homozygously between groups with significant protein impact prediction confidence. Three SNPs discriminating between populations were predicted to significantly affect protein tertiary structure ([Table 2](#t0020){ref-type="table"}). The first of these was a P860L change that was unique to populations In/Np 1, 2 and 3 along with strain 597LN in the 5′ A2-related gene (LdBPK_220660), upstream of the A2 locus. This gene is expressed only during host infection ([@b0125; @b0355]), is involved in promastigote-amastigote stage differentiation ([@b0015]), and here also had a heterozygous substitution (T1036M) partitioning the same groups with a significant predicted functional impact. Two other amino acid mutations in mannosyltransferase (LdBPK_311920) and fatty acid desaturase (LdBPK_261680) genes also differentiated the In/Np 1, 2 and 3 set from the remainder.

Three protein-level mutations observed here occurred in genes previously implicated in antimonial resistance, though only one could distinguish to some extent the *in vitro* SSG phenotypes. This mutation in the rhomboid protein serine peptidase gene (LdBPK_040850) was predicted to have a significant functional impact (A113V) and separated a distinct population composed solely of SSG-resistant strains (In/Np 3) from the others. Furthermore, none of the patients from which the In/Np 3 strains were isolated responded to SSG treatment. The first of the two other variants was a S890N polymorphism unique to population In/Np 2 in a gene encoding ubiquitin-activating enzyme e1 (LdBPK_230710) that has been linked with resistance *in vitro* ([@b0270]). This gene product was more highly expressed in bone marrow aspirates of VL patients than in skin lesions of either PKDL or CL patients, implying a possible involvement in disease pathology ([@b0285]). The second change (G130S) was unique to BPK294/0cl1 and occurred in a tryparedoxin gene (LdBPK_291220) whose product is immunogenic in hosts ([@b0055]) and is more highly expressed in strains resistant to antimonials ([@b0340]). The protein is associated with defence against oxidative stress, like that from anti-leishmanial drugs, by maintaining thiol metabolism, and the associated tryparedoxin pathway may be subject to directional selection ([@b0085]).

The phylogenetic relationship revealed by genome-wide SNP typing differed slightly from previous kDNA work ([@b0035]): In/Np 2, along with BPK035/0cl1 and BPK043/0cl2 from In/Np 1, formed a separate cluster from In/Np 1 and 3 ([Supplementary Fig. 7](#s0080){ref-type="sec"}). Considering the differing modes of inheritance between kDNA and chromosomal DNA this might reflect recombination among closely related strains. The low level of admixture in the strains BPK035/0cl1 and BPK043/0cl2 for the clusters In/Np 1 and 2 ([Fig. 3](#f0015){ref-type="fig"}) suggests that a wider panel of SNPs may be required to test this. Additionally, these two strains could represent another functionally and genetically distinct focus of *L. donovani* diversity from this area ([Supplementary Fig. 4](#s0080){ref-type="sec"}) given their high number of unique alleles (such as G443E in protein kinase gene LdBPK_271290).

A protein-level mutation (V185M) in the NADH-flavin oxidoreductase/NADH oxidase gene (LdBPK_120730) unique to BPK026/0cl5, BPK031/0cl12 and the two Kenyan strains (NLB218 and LRC-L53) may be involved in promastigote-amastigote development ([@b0260]). The V185 variant was verified in Illumina reads for BPK026/0cl5 mapped to the reference *L. donovani* genome sequence (unpublished data); in contrast, the Spanish reference *L. infantum* genome for JPCM5 has the M185 allele (<http://www.genedb.org>). Finally, a G443E substitution in a gene encoding a protein kinase (LdBPK_271290) unique to BPK035/0cl1 and BPK043/0cl2 had a significant predicted functional impact.

4. Conclusions {#s0060}
==============

We investigated the genetic relationships of *Leishmania* using traditional microsatellite and genome-wide SNP markers in order to resolve variation in strains from Nepal and India and the wider *L. donovani* species complex, and to compare the power of these two marker systems. In this study, we found that microsatellites present strains from the Bihar state of India and Terai region of Nepal as a single homogeneous cluster, like previous studies using MLMT ([@b0005]). In contrast, SNP data provided compelling evidence that multiple lineages are circulating in this small region. It is clear that more genetically divergent and novel lineages will be observed in regions endemic for VL with more comprehensive sampling.

The hypothesis of a population bottleneck followed by a recent clonal expansion of strains from Terai and Bihar is supported here by the nodular and star-like structure of the SNP-based phylogenetic networks. Furthermore, simulations of the population history were symptomatic of such a scenario, and intriguingly the peak bottleneck point falls soon after the insecticide-driven parasite elimination programs in the 1960s. However, our survey here indicates that neither the number of expansions in this small geographic area nor the number of origins of drug resistance can be clearly resolved without deeper and wider sampling. The proposed recent population contraction needs to be considered in a framework of likely cyclical population changes associated with drug-driven directional selection for new advantageous alleles, which may be accelerated by the increased fitness in drug-resistant variants from the same area ([@b0325; @b0215]). Sharp selective sweeps driven by chemotherapeutic drugs would lead to reduced genetic variation ([@b0140]), but here we show evidence of recombination and a distinct hub of diversity in this region, countering the pervasive pattern of genetic homogeneity and lending support to the idea of periodised epidemiological shifts interspersing clonal outbreaks.

Insights on additional factors modulating the evolution of these strains comes from the phylogenetic grouping of strains isolated prior to and following the 1960s parasite elimination schemes in the Indian subcontinent ([Fig. 1](#f0005){ref-type="fig"}). Indian strain L13 (from 1961) clustered with Sudan samples from the 1990s, and older Indian isolates (LRC-L51p and SC23, both 1954) grouped with both Kenyan strains of the same era (LRC-L53, 1955; LRC-L57, 1962) and also with more recent ones from India (LRC-L51a, 1971) and Kenya (NLB189, 1983; NKB218, 1984; NLB323, 1985). Coupling these observations with the detection of a divergent lineage from Nepal in this study suggests that the diverse lineages of *L. donovani* that contributed to re-emergence of the leishmaniases as a major disease burden in the Indian subcontinent are likely to persist, and may provide a reservoir of diversity for future epidemics and treatment resistance. Consequently, wider sampling of *Leishmania* parasites resistant to treatment drugs and isolated from asymptomatic infections ([@b0240]) is required to evaluate this hypothesis.

While the advantages of using genome-wide SNPs as a basis for evaluating population-level variation in *Leishmania* populations are illustrated here, there are limitations to SNP-based analyses that require noting. Phylogenetic distances may be skewed by both the under-representation of rare alleles ([@b0070]) and also by adaptive processes ([@b0255]). Additionally, there is an ascertainment bias for quantifying relationships for markers designed to be informative for different datasets; here, we designed a SNP panel to resolve population-level relationships, and consequently the inter-population distances were qualitative rather than quantitative due to the fixation of population-level variants in the outgroup strains ([@b0010]). Combining the relative power of each marker system by resolving inter-population groups with microsatellites, and intra-population structure using SNPs may help maximise the information output ([@b0130]). However, the resolving power will depend on the extent of SNP and microsatellite concordance ([@b0320]), as well as the effects of adaptive evolution or population size change ([@b0310]) and the level of genetic differentiation ([@b0255]).

Given the increased power of SNPs compared to microsatellites in clarifying the structure of closely related populations in other species ([@b0200; @b0305]), this paper highlights the relevance of harnessing new sequencing technologies in exploring the epidemiology of infectious diseases. Moreover, it provides evidence that only complete genomes will provide a comprehensive phylogenetic profile of diversity within and between *Leishmania* species and populations ([@b0315]), especially in light of the extensive structural variation in *Leishmania* ([@b0085; @b0250]).

Author contributions {#s0065}
====================

G.S., J.C.D., M.B., O.S. and T.D. designed the study. I.M., M.S., M.V., S.D.D., S.D., S.R. and S.S. collected, documented and maintained samples. H.I., O.S. and T.D. examined sequence data. O.S. and T.D. performed analyses. G.S., J.C.D., M.B., O.S. and T.D. wrote the manuscript.

Appendix A. Supplementary data {#s0080}
==============================

Supplementary data

We thank the Genotyping and Parasite Genomics teams, Susana G. Campino and Taane G. Clark (all Wellcome Trust Sanger Institute, UK). We also thank Jean-Pierre Dedet, Nadira Karunaweera, Isabel Mauricio, Henk Schallig and Lionel F. Schnur for the donation of parasite cultures and DNA samples. This work was funded by the Wellcome Trust (Grant No. WT 085775/Z/08/Z), by the Kaladrug (Grant No. EC-FP7-222895, [www.leishrisk.net/kaladrug](http://www.leishrisk.net/kaladrug)) and Gemini (Grant No. ITMA SOFI-B, [www.leishrisk.net/gemini](http://www.leishrisk.net/gemini)) consortia, the Baillet-Latour Foundation and the Agency for Innovation by Science and Technology in Flanders (IWT).

Supplementary data associated with this article can be found, in the online version, at [doi:10.1016/j.meegid.2011.11.005](10.1016/j.meegid.2011.11.005).

![Phylogenetic relationships of *L. donovani* complex strains using microsatellite profiling. A midpoint-rooted neighbour-joining tree constructed from microsatellite data for 193 *L. donovani* complex strains with MEGA using the minimum evolution method. Sub-populations determined with structure (for *K* = 3) are shown as coloured boxes for In^1,2^NpBdLk (grey, top: India, Nepal, Bangladesh and Sri Lanka), KeSdEtIn^3,4^ (dark grey, middle: Kenya, Sudan, Ethiopia and India) and *L. infantum* (pale grey, bottom). Numbers beside samples indicate strains that shared identical microsatellite profiles. One hundred and eight strains had genotype 1a (marked with a pink box); of which those 18 were also SNP genotyped. The most divergent Nepalese strains are marked with green boxes (BPK026/0cl5, BPK031/0cl12, BPK406/6). L60b represents both Sri Lankan strains (the other is L60c). LRC-L51p (orange box) represents two other Indian strains (LRC-L51a and SC23): these grouped with the Kenyan samples. Indian strain L13 (black box) clustered with the Sudanese and Ethiopian strains. Strains subjected to SNP genotyping are highlighted as SSG-resistant (red) and -susceptible (blue). Branch lengths are proportional to the genetic distance: values greater than 0.1 are shown above the branch. Bootstrap values were determined with Populations software for 10^3^ replicates: values greater 87% are shown below the node.](gr1){#f0005}

![Phylogenetic relationships of strains from the *L. donovani* complex from (A) microsatellite and (B) SNP data. Midpoint-rooted neighbour-joining trees constructed for 33 *L. donovani* complex strains with MEGA using: (A) microsatellite data for *K* = 3 geographical populations called InNp (grey containing Indian -- denoted BHU -- as well as Nepalese strains named BPK), KeSdEtLk (dark grey, *L. donovani* from Kenya, Sudan, Ethiopia and Sri Lanka) and *L. infantum* (pale grey from China and France) -- notably, BPK026/0cl5 and BPK031/0cl12 cluster in the InNp group for microsatellites; and (B) SNP data for *K* = 4 populations denoted In/Np 1 (yellow), 2 (blue) and 3 (green), which were composed of strains from India and Nepal; and Inf/Afr/Div (mauve), which represented Kenyan, Sudanese, Ethiopian, Sri Lankan, Chinese and French *L. donovani* complex strains in addition to two Nepalese samples (BPK026/0cl5 and BPK031/0cl12). Populations were determined using structure for both marker types. *In vitro* responses to SSG are shown as resistant (red) or sensitive (blue). Bootstrap values were determined for 10^4^ (SNPs) or 10^3^ (microsatellites) replicates -- only those with more than 87% confidence are shown at each node. Branch lengths are proportional to the genetic distance.](gr2){#f0010}

![Comparative estimation of population membership for 33 *L. donovani* species complex strains using microsatellite (top) and SNP (bottom) profiling. The assignation probabilities of each strain to populations determined by structure clustering for 33 *L. donovani* samples for: (top) microsatellite loci for *K* = 3 populations shown as InNp in grey (India, named BHU, and Nepal, called BPK), *L. infantum* in pale grey (French and Chinese), and KeSdEtLk in dark grey (Kenyan, Sudanese, Ethiopian and Sri Lankan *L. donovani*); and (bottom) SNP typing for *K* = 5 4 called In/Np 1 in yellow (India and Nepal), In/Np 2 in blue, In/Np 3 in green and Inf/Afr/Div in mauve (BPK026/0cl5 and BPK031/0cl12 from Nepal and Kenyan, Sudanese, Ethiopian, Sri Lankan, Chinese and French *L. donovani* complex strains). Strain colours show the *in vitro* response to SSG exposure as resistant (red) or sensitive (blue). BPK026/0cl5 and BPK031/0cl12 consistently clustered with the global *L. donovani* and *L. infantum* strains for *K* \> 1 SNP-ascertained populations, in contrast to their assignation with microsatellites. A fifth hypothetical SNP-based population cluster (shown in black at strain BPK067/0cl2) that had no exclusive ancestry of individual strains suggested the possible circulation of further distinct genetic groups in this small region.](gr3){#f0015}

###### 

Geographic origins, phylogenetic clustering and *in vitro* phenotypes of the strains assessed using both microsatellite and SNP markers.

  WHO strain code                                              *M*/sat[b](#tblfn2){ref-type="table-fn"}   SNP[c](#tblfn3){ref-type="table-fn"}   *M*/sat *K* = 3[d](#tblfn4){ref-type="table-fn"}   Country     SSG[e](#tblfn5){ref-type="table-fn"}
  ------------------------------------------------------------ ------------------------------------------ -------------------------------------- -------------------------------------------------- ----------- --------------------------------------
  MHOM/CN/1978/D2                                              6                                          Inf/Afr/Div                            *L. infantum*                                      China       --
  MHOM/ET/1972/GEBRE1                                          3f                                         Inf/Afr/Div                            KeSdEtIn^3,4^                                      Ethiopia    --
  MHOM/SD/1993/597LN                                           3g                                         Inf/Afr/Div                            KeSdEtIn^3,4^                                      Sudan       --
  MHOM/FR/1962/LRC-L47                                         6                                          Inf/Afr/Div                            *L. infantum*                                      France      --
  MHOM/FR/1995/LPN114                                          6                                          Inf/Afr/Div                            *L. infantum*                                      France      --
  MHOM/KE/1955/LRC-L53                                         2d                                         Inf/Afr/Div                            KeSdEtIn^3,4^                                      Kenya       --
  MHOM/KE/1984/NLB218                                          2b                                         Inf/Afr/Div                            KeSdEtIn^3,4^                                      Kenya       --
  MHOM/LK/2002/L60b                                            4b                                         Inf/Afr/Div                            In^1,2^NpBdLk                                      Sri Lanka   --
  MHOM/IN/2009/BHU568/0cl1[a](#tblfn1){ref-type="table-fn"}    1a                                         In/Np 3                                In^1,2^NpBdLk                                      India       R
  MHOM/IN/2009/BHU573/0cl3[a](#tblfn1){ref-type="table-fn"}    1a                                         In/Np 3                                In1^,2^NpBdLk                                      India       R
  MHOM/NP/2002/BPK025/0cl1                                     1a                                         In/Np 1                                In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2002/BPK026/0cl5                                     1x                                         Inf/Afr/Div                            In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2002/BPK029/0cl6                                     1a                                         In/Np 1                                In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2002/BPK031/0cl12                                    1z                                         Inf/Afr/Div                            In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2002/BPK035/0cl1[a](#tblfn1){ref-type="table-fn"}    1b                                         In/Np 1                                In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2002/BPK043/0cl2[a](#tblfn1){ref-type="table-fn"}    1b                                         In/Np 1                                In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2002/BPK067/0cl2[a](#tblfn1){ref-type="table-fn"}    1j                                         In/Np 3                                In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2002/BPK077/0cl5                                     1a                                         In/Np 2                                In^1,2^NpBdLk                                      Nepal       --
  MHOM/NP/2002/BPK080/0cl1[a](#tblfn1){ref-type="table-fn"}    1a                                         In/Np 1                                In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2002/BPK081/0cl8                                     1a                                         In/Np 1                                In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2002/BPK085/0[a](#tblfn1){ref-type="table-fn"}       1a                                         In/Np 1                                In^1,2^NpBdLk                                      Nepal       R
  MHOM/NP/2002/BPK087/0cl11[a](#tblfn1){ref-type="table-fn"}   1a                                         In/Np 1                                In^1,2^NpBdLk                                      Nepal       R
  MHOM/NP/2002/BPK164/1cl11                                    1a                                         In/Np 3                                In^1,2^NpBdLk                                      Nepal       R
  MHOM/NP/2002/BPK173/0cl3[a](#tblfn1){ref-type="table-fn"}    1a                                         In/Np 3                                In^1,2^NpBdLk                                      Nepal       R
  MHOM/NP/2002/BPK173/1cl9                                     1a                                         In/Np 3                                In^1,2^NpBdLk                                      Nepal       R
  MHOM/NP/2002/BPK178/0cl3[a](#tblfn1){ref-type="table-fn"}    1a                                         In/Np 2                                In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2003/BPK190/0cl3[a](#tblfn1){ref-type="table-fn"}    1a                                         In/Np 1                                In^1,2^NpBdLk                                      Nepal       R
  MHOM/NP/2003/BPK206/0cl10                                    1a                                         In/Np 1                                In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2003/BPK275/0cl18                                    1a                                         In/Np 3                                In^1,2^NpBdLk                                      Nepal       R
  MHOM/NP/2003/BPK282/0cl4[a](#tblfn1){ref-type="table-fn"}    1a                                         In/Np 2                                In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2003/BPK288/0                                        1a/1 k                                     In/Np 2                                In^1,2^NpBdLk                                      Nepal       R
  MHOM/NP/2003/BPK294/0cl1[a](#tblfn1){ref-type="table-fn"}    1d                                         In/Np 2                                In^1,2^NpBdLk                                      Nepal       S
  MHOM/NP/2003/BPK298/0cl8[a](#tblfn1){ref-type="table-fn"}    1a                                         In/Np 1                                In^1,2^NpBdLk                                      Nepal       S

The strains are listed alphabetically according to their WHO strain codes. See [Supplementary Table 2](#s0080){ref-type="sec"} for a complete list of all 193 strains examined.

Strains with published genome sequences: BPK282/0cl4 is the reference genome strain.

The microsatellite-determined genotypes: those for BPK026/0cl5 (1x) and BPK031/0cl12 (1z) are new.

Groups assigned for SNPs for *K* = 3 populations for strains as shown in [Fig. 2](#f0010){ref-type="fig"}B: Inf/Afr/Div stands for Kenyan, Sudanese, Ethiopian, Sri Lankan, Chinese and French *L. donovani* complex strains and two Nepalese samples (BPK026/0cl5 and BPK031/0cl12); and In/Np stands for India and Nepal.

Groups assigned according to microsatellite variability for *K* = 3 populations for 193 samples ([Fig. 1](#f0005){ref-type="fig"}): KeSdEtIn^3,4^ stands for Kenyan, Sudanese, Ethiopian and Indian isolates; In^1,2^NpBdLk for Indian, Nepalese, Bangladeshi and Sri Lankan strains.

*In vitro* phenotype for SSG: resistant (R) or sensitive (S). All samples caused VL except for NLB218 and 597LN (PKDL) and L60b (CL).

###### 

Protein-coding SNPs in known genes differentiating *L. donovani* phylogenetic groups.

  Chr   Genome position   Amino acid                               Gene product                                                                  Gene ID        Differentiated groups
  ----- ----------------- ---------------------------------------- ----------------------------------------------------------------------------- -------------- ------------------------------------------
  31    930,958           E679G                                    Mannosyltransferase                                                           LdBPK_311920   In/Np 1, 2, 3; 597LN
  22    303,316           P860L[a](#tblfn6){ref-type="table-fn"}   5′ a2rel-related protein[b](#tblfn7){ref-type="table-fn"}                     LdBPK_220660   In/Np 1, 2, 3
  26    610,539           D14E                                     Fatty acid/sphingolipid δ-4 desaturase                                        LdBPK_261680   In/Np 1, 2, 3 (except BPK067/0cl2)
  28    1023,334          N839S                                    Splicing factor 3B subunit 1                                                  LdBPK_282780   In/Np 1 (except BPK025/0cl1)
  23    255,065           S890N                                    Ubiquitin-activating enzyme e1[c](#tblfn8){ref-type="table-fn"}               LdBPK_230710   In/Np 2
  29    545,079           S18N                                     Serine/threonine-protein kinase                                               LdBPK_291420   In/Np 2
  4     337,729           A113V[a](#tblfn6){ref-type="table-fn"}   Rhomboid protein serine peptidase Clan S, family S54                          LdBPK_040850   In/Np 3[d](#tblfn9){ref-type="table-fn"}
  12    483,640           V185M                                    NADH: flavin oxido-reductase/NADH oxidase[e](#tblfn10){ref-type="table-fn"}   LdBPK_120730   Kenyan; BPK026/0cl5; BPK031/0cl12
  27    509,391           G443E[a](#tblfn6){ref-type="table-fn"}   Protein kinase                                                                LdBPK_271290   BPK035/0cl1; BPK043/0cl2
  29    457,404           G130S                                    Tryparedoxin[f](#tblfn11){ref-type="table-fn"}                                LdBPK_291220   BPK294/0cl8
  18    233,653           C34Y                                     RNA binding protein                                                           LdBPK_180590   BPK067/0cl1

Phylogenetically informative protein sequence homozygous SNPs observed in genes with known or proposed functions. The Nepalese clusters were the major groups distinguished by Bayesian clustering ([Fig. 3](#f0015){ref-type="fig"}).

Mutation is predicted to have a significant impact on protein function.

Involved in promastigote--amastigote stage differentiation ([@b0015]).

ssociated with SSG resistance ([@b0270]) and disease pathology ([@b0285]).

All strains were SSG-resistant.

Implicated in promastigote-amastigote development ([@b0260; @b0285]); the Kenyan strains are NLB218 and LRC-L53.

Associated with antimonial drug resistance ([@b0340]) and host immunogenicity ([@b0065]).
